These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2051706)

  • 41. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK; Kim CT; Song SD
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The detection and significance of HBV-DNA in serum of pulmonary tuberculous patients].
    Xu F; Chen H; Yan B
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Aug; 18(4):212-4, 254. PubMed ID: 8697511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide].
    Savula MM; Smolenko MI; Romaniuk MD; Slivka IuI
    Probl Tuberk; 1990; (11):25-8. PubMed ID: 2290809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute pancreatitis in patients with pulmonary tuberculosis].
    Sementsov IIa
    Probl Tuberk; 2000; (2):33-5. PubMed ID: 10838907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y; Oka M
    Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
    Sato K; Nagai H; Kurashima A; Mori M; Katayama T
    Kekkaku; 1995 Oct; 70(10):585-9. PubMed ID: 8523851
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
    Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction.
    Yew WW; Chau CH; Wong PC; Lee J; Wong CF; Cheung SW; Chan CY; Cheng AF
    Drugs Exp Clin Res; 1995; 21(2):79-83. PubMed ID: 7555613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver alterations in antituberculosis regimens containing pyrazinamide.
    Pilheu JA; De Salvo MC; Koch O
    Chest; 1981 Dec; 80(6):720-2. PubMed ID: 7307595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chemotherapy of pulmonary tuberculosis with liver damage].
    Overrath H
    Prax Pneumol; 1973 Mar; 27(3):182-90. PubMed ID: 4699468
    [No Abstract]   [Full Text] [Related]  

  • 52. Resolution of diffuse granulomatous fibrosis of the liver with antituberculous chemotherapy.
    Okuda K; Kimura K; Takara K; Ohto M; Omata M; Lesmana L
    Gastroenterology; 1986 Aug; 91(2):456-60. PubMed ID: 3522343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic cytolysis and bicytopenia after 15 days of four-drug tuberculosis treatment in Senegal.
    Thiam K; Sagne JMAN; Ndiaye EHM; Cissé MF; Mbaye FBR; Touré NO; Dia Kane Y; Diatta A; Niang S; Kombila UD; Dia S; Ndao M; Ka W
    Med Sante Trop; 2017 Aug; 27(3):233-234. PubMed ID: 28947398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic results using Hepsan in liver-damaged tuberculosis patients].
    Olbrich H
    Z Allgemeinmed; 1975 Jun; 51(18):837-8. PubMed ID: 1224651
    [No Abstract]   [Full Text] [Related]  

  • 55. Rifabutin treatment for tuberculosis patients with liver function abnormalities.
    Mancini P; Pasqua F; Mazzei L; Olliaro P
    J Antimicrob Chemother; 1992 Aug; 30(2):242. PubMed ID: 1328137
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatic damage in chronic pulmonary tuberculosis.
    BAN B
    Am Rev Tuberc; 1955 Jul; 72(1):71-90. PubMed ID: 14388210
    [No Abstract]   [Full Text] [Related]  

  • 57. Functional hepatic impairment in pulmonary tuberculosis.
    GALEN RS; WEINER D; HARTMAN SA
    Dis Chest; 1950 May; 17(5):524-31. PubMed ID: 15411859
    [No Abstract]   [Full Text] [Related]  

  • 58. [Constitutional hepatic dysfunction; a case report].
    CHANG KJ; CHANG SH
    Zhonghua Nei Ke Za Zhi; 1958 Sep; 6(9):903-5; English abstract 105-6. PubMed ID: 13608733
    [No Abstract]   [Full Text] [Related]  

  • 59. On the Functions of the Liver.
    Buffalo Med J Mon Rev Med Surg Sci; 1851 Nov; 7(6):363-366. PubMed ID: 35375674
    [No Abstract]   [Full Text] [Related]  

  • 60. [Chemotherapeutic evaluation of pulmonary tuberculosis patients with a complication of hepatic dysfunction].
    Shichi I; Sato A; Chida K; Yasuda K; Tatsuta Y; Honda A; Wada R; Yamazaki A
    Kekkaku; 1991 Apr; 66(4):309-17. PubMed ID: 2051706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.